MTITSE:9438 -0.37%72 Net Margin % is 15.97% as of Mar. 2026, which is 213% above its 10-year median of 5.10. GuruFocus rates TSE:9438 with a GF Score™ of 72/100 and a GF Value™ of 円847.15 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 665 Healthcare Providers & Services companies, MTI ranks better than 82.41% on this metric.
Net margin is calculated as Net Income divided by its Revenue. MTI's Net Income for the
three
months ended in Mar. 2026 was 円1,261 Mil. MTI's Revenue for the
three
months ended in Mar. 2026 was 円7,893 Mil. Therefore, MTI's net margin for the quarter that ended in Mar. 2026 was 15.97%.
The historical rank and industry rank for MTI's Net Margin % or its related term are showing as below:
TSE:9438'
s Net Margin % Range Over the Past 10 Years
Min: -4.52 Med: 5.1 Max: 11.44
Current: 11.44
TSE:9438's Net Margin % is ranked better than 82.41% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.89
vs TSE:9438: 11.44
MTI (TSE:9438) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MTI Net Margin % Related Terms
MTI Net Margin % Historical Data
* Premium members only.
The historical data trend for MTI's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9438 vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, MTI's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MTI Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MTI's Net Margin % distribution charts can be found below:
* The bar in red indicates where MTI's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MTI (TSE:9438) has a Net Margin % of 15.97% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on MTI and its competitors. This is 213% above median its historical median of 5.10. According to the industry distribution chart, MTI ranks #117 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 17.6%.
Is MTI's Net Margin % too high?
MTI's current Net Margin % of 15.97% is 213% above median its 10-year median of 5.10. The Healthcare Providers & Services industry median Net Margin % is 2.89. MTI's value of 15.97% is 452.6% above this industry median. Based on the distribution chart, MTI ranks #117 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MTI has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MTI's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MTI ranks #117 out of 665 companies for Net Margin %. This places MTI in the top 18% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. MTI's value of 15.97% is 452.6% above this benchmark. While the company's 10-year median is 5.10 vs. the industry median of 2.89, MTI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MTI's current Net Margin % of 15.97% is 452.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MTI and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MTI's current Net Margin % is 15.97%, which is 213% above median its own 10-year median of 5.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MTI stock overvalued right now?
Based on GuruFocus' analysis, MTI (TSE:9438) is currently considered Significantly Undervalued. The stock's GF Value™ is 円847.15, compared to a current price of 円536.00 — trading 36.7% below its estimated fair value. The current Net Margin % is 15.97%, which is 213% above median its 10-year median of 5.10 and 452.6% above the Healthcare Providers & Services industry median of 2.89. MTI's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MTI (TSE:9438), the current Net Margin % is 15.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MTI (TSE:9438) Overvalued in 2026?
Based on GuruFocus' analysis, MTI stock appears to be undervalued.
The current stock price of 円536.00 is trading 36.7% below its estimated GF Value™ of 円847.15.
GuruFocus considers MTI to be Significantly Undervalued.
Key valuation signals for TSE:9438:
Net Margin %: 15.97% (213% above median its 10-year median of 5.10)
GF Value™: 円847.15 vs. price of 円536.00 (36.7% below fair value)
Industry Position: 452.6% above the Healthcare Providers & Services median (#117 of 665)
No single metric tells the full story. See the TSE:9438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MTI Ltd is engaged in the content distribution business for mobile phones in Japan. The company provides health care services through Lunaruna app, Lunaruna baby, and Lunaruna medicine notebook. It is involved in providing music/video services, electronic book services, life information services, and entertainment services.
72GF Score
Get the complete analysis for TSE:9438
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9438 has been successfully added to your 
